arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Friday 2 July 2021

Friday 02 Jul

SESSION 5: HOW TO COMBINE IMMUNOTHERAPY WITH STANDARD OF CARE

Chair: Andreas Dietz, Germany & Moderator Ana Ferreira Castro, Portugal

08:30

Keynote lecture: Checkpoint inhibition in the radical setting for H&N SCC

Lisa Licitra, Italy

09:00

Neo-adjuvant immunotherapy in HNSCC

Charlotte Zuur, The Netherlands

09:15

Radiation with immunotherapy

Kevin Harrington, United Kingdom

09:30

Therapeutic vaccines in HPV+ disease

Christophe Le Tourneau, France

Proferred papers related to session 5

Chair: Drago Prgomet, Coatia & Moderator: Vincent Grégoire, France

09:45

5.1 Evaluation of pembrolizumab monotherapy in patients with salivary gland carcinoma in the phase 2 KEYNOTE-158 study

Caroline Even, France

09:55

5.2

10:05

5.3 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in patients with advanced cancers: phase I trial

Colette Shen, USA

10:15

Coffee Break

SESSION 6: HOW WILL WE TREAT OUR PATIENTS NON-SURGICALLY IN 2030?

Chair: Jesper Grau-Eriksen, Denmark & Jean-Pascal Machiels, Belgium

10:45

Adaptive radiotherapy for dummies

Edmond Sterpin, Belgium

11:05

Treatment adaptation for HPV positive disease.

Pernille Lassen, Denmark

11:25

Systemic therapy: immune checkpoint inhibitors, still cisplatin, …

Sylvie Rottey, Belgium

Proferred papers related to session 6

Chair: Igor Reshetov, Russia & Moderator: Paul Clement, belgium

11:45

6.1 Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of locally advanced HNSCC in elderly patients: a phase I/II study

Christophe Le Tourneau, France

11:55

6.2 Validation of USPIO-enhanced MRI for detection of lymph node metastases in head and neck carcinoma: a pilot study

D.A.J.J. Driessen, The Netherlands

12:05

6.3 Can imaging alone replace panendscopy as a ‘gold standard’ investigation for patients with low risk features for oropharyngeal cancer?

Carolina Watters, United Kingdom

12:15

6.4 The virtual MDT - the future or a fad?

Hussein Mohamedbhai, USA

12:25

Concluding remarks

12:30

Lunch / virtual booth visit

12:45

Satellite Symposium

Visit : https://www.echno-ichno2021.org/sponsored-symposia-2/

SESSION 7: QUALITY OF CARE IN TREATMENT OF HEAD AND NECK CANCER AND SURVIVORSHIP

Chair: Andreas Dietz, Germany & Moderator: G. Succo, Italy

14:00

How to improve Quality of Care in Surgical Oncology.

René Leemans, The Netherlands

14:20

What really matters is the radiation oncologist behind the machine

Vincent Grégoire, France

14:40

Optimizing the prescription doses and tolerability of systemic therapy

Thorsten Fureder, Austria

15:00

Health related quality of life from diagnosis up to 2 years after treatment: evidence from NET-QUBIC

Irma Verdonck-de Leeuw, The Netherlands

15:20

Value based health care.

Yolande Lievens, Belgium

Proferred papers related to session 7

Chair: Fréderic Duprez, Belgium & Moderator: Susanne Singer, Germany

15:40

7.1 The positive yield of multidisciplinary team decisions in a high volume head and neck center after those made in its preferred partner: An example of enhanced quality of care

J.J. Hendrickx, The Netherlands

15:50

7.2 Do head and neck cancer patients in randomized trials represent the population in daily practice?

Johannes H.A.M. Kaanders, The Netherlands

16:00

Coffee Break

SESSION 8: THYROID CANCER

Chair: Dimitrios Moraitis, Greece & Moderator: Guy Andry, Belgium

16:30

Surveillance vs. treatment of papillary thyroid cancer

Iain Nixon, United Kingdom

16:50

New treatment options in iodine-refractory thyroid cancer

Laura Locati, Italy

Proferred papers related to session 8

Chair: Ricard Simo, United Kingdom

17:10

8.1 Further progress in the detection of thyroid carcinoma: the microRNAs supplant the gene mutations in fine-needle aspiration biopsies.

M. Quiriny, Belgium

17:20

8.2 A Comparison of Differentiated Thyroid Cancer Presenting in the UK Versus Internationally

Rupali Sawant, United Kingdom

17:30

8.3

17:40

8.4 Correlation between thyroid fine needle aspiration cytology and post-operative histology: A 10-year single-centre experience

Ahmad Abou-Foul, United Kingdom

17:50

Concluding remarks

Ricard Simo, United Kingdom